Lilly to sell heartworm line for Novartis deal approval
Eli Lilly and Co. wants to combine Novartis with its own animal health business, Elanco, to create the second-largest animal health company in the U.S.
Health Care & Insurance
Articles
Obamacare brings boost to WellPoint
WellPoint’s stock price rose 53 percent from Sept. 30, 2013—the day before the Obamacare insurance exchanges started up—until Dec. 19, 2014, when the price closed at $127.95.
2014 NEWSMAKER: Zeke Turner
Zeke Turner, CEO of Carmel-based Mainstreet, stepped up expansion after he beat back a legislative push by nursing home companies to place a moratorium on new construction.
Indiana again ranks 41st in U.S. health survey
While the state was strong with regards to immunizations, infectious diseases and binge drinking, it still has work to do in physical activity, obesity, and air pollution.
Conner Insurance to invest $1M, add up to 23 workers
The expansion at Keystone at the Crossing would nearly double the insurance brokerage firm's Indiana workforce to 49.
Indy hospitals stung by Medicare penalties for patient injuries
Five Indianapolis-area hospitals stand to lose more than $7 million in Medicare payments as a penalty for having rates of infections and patient injuries that run higher than most hospitals nationwide.
Zimmer to pay Stryker $70M in surgical device fight
The award is actually less than a third of what Warsaw-based Zimmer was originally ordered to pay for infringing patents on a lavage device.
Lilly reaches insulin development deal with Adocia
Eli Lilly and Co. could pay more than $570 million to French pharmaceutical company Adocia under an agreement to develop a fast-acting insulin that is in the early stages of clinical testing.
Pence: HIP 2.0 timeline not as important as approval
The state and federal government have been in negotiations since the summer, but the governor said he remains confident that an agreement will be reached, even if it isn’t by his original deadline.
Lilly bumps up dividend for first time since 2009
Shares of Eli Lilly and Co. were on the rise Tuesday morning, a day after the drugmaker announced its first dividend increase in more than five years.
Drug delivery firm plans distribution center, 46 jobs
Simple Meds LLC, an Indianapolis-based startup, is seeking a city tax break that will help it open a local distribution facility and hire up to 46 people by the end of 2020.
Lilly’s Cyramza gets new marketing approval
Eli Lilly and Co.'s drug Cyramza has been approved as a treatment for lung cancer, regulators said. The Food and Drug Administration is allowing Lilly to market the drug as a treatment for cases that have spread.
Alzheimer’s tests present dilemma of knowing the future
While the tests will likely help drug companies like Eli Lilly and Co. evaluate medicines, they’ll also create wrenching personal and ethical dilemmas for patients who will have to live with the knowledge that they’re destined to develop the disease.
Indy dentist accused of $260,000 in false claims
Marion County Prosecutor Terry Curry said Dr. Bernice Avant was charged Thursday with one count of Medicaid fraud and four counts of theft.
The moving target bedeviling attempts to cut health care costs
In health care, 5 percent of patients account for 50 percent of costs. Trouble is, those patients aren’t the same from year to year. Not even close.
Report: Nearly 43 million Americans have unpaid medical bills
The findings suggest that many Americans are being trapped by debt because they are confused by the notices they get from hospitals and insurance companies about the cost of treatment.
Covance shareholder sues over $6.1B LabCorp deal
A Covance Inc. investor contends in a lawsuit that the drug-testing company’s board erred in relying on what the shareholder called Goldman Sachs Group Inc.’s conflict-tainted advice. Covance has major laboratory operations in Indianapolis.
Nearly $50M in state funds sought for medical campus
Officials from three state universities seek almost $50 million in state funding for a planned medical school campus they would share in downtown Evansville. That’s up from the original plan of $35 million.
Lilly rheumatoid arthritis drug meets goals in final-stage trial
If approved, Baricitinib may bring Lilly $673 million in 2020, according to the average of five analysts’ estimates compiled by Bloomberg.
Hoosier docs, hospitals cut jobs while peers nationally keep hiring
In spite of the divergent trend, Indiana still employs more workers in hospitals and doctors’ offices than the nation as a whole.